CALCITONIN-SALMON (calcitonin,salmon,synthetic)

There are 0 contraindications.

There are 2 severe contraindications. Adequate patient monitoring is recommended for safer drug use.

Severe List
Hypocalcemia
Vitamin D deficiency

There are 1 moderate contraindications. Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.

Moderate List
Malignancy

There are 28 severe adverse reactions.

More Frequent	Less Frequent
Crusted nasal mucosa Dry nose Nasal passage irritation Rhinitis	Angina Bronchospastic pulmonary disease Cystitis Hypertension Infection Lymphadenopathy Upper respiratory infection

Rare/Very Rare
Acute myocardial infarction Anaphylaxis Bundle branch block Cerebrovascular accident Goiter Hearing loss Hepatitis Hyperthyroidism Hypocalcemia Hypocalcemic tetany Lesion of nasal mucosa Malignancy Nasal septal ulcers Pneumonia Polymyalgia rheumatica Pruritus of skin Seizure disorder

There are 48 less severe adverse reactions.

More Frequent	Less Frequent
Arthralgia Back pain Epistaxis Headache disorder	Abdominal pain with cramps Conjunctivitis Constipation Depression Diarrhea Dizziness Dyspepsia Eye tearing Fatigue Flu-like symptoms Myalgia Nausea Paresthesia Sinusitis Skin rash

Rare/Very Rare
Agitation Alopecia Anorexia Cough Dysgeusia Dyspnea Eczema Facial edema Fever Flatulence Flushing Gastritis Hyperhidrosis Increased appetite Insomnia Nasal congestion Palpitations Parosmia Peripheral edema Pharyngitis Sneezing Symptoms of anxiety Tachycardia Tinnitus Tremor Vertigo Visual changes Vomiting Xerostomia

Calcitonin salmon has been shown to decrease fetal birthweight in rabbits when given in dosages 14-56 times the recommended human parenteral dose. Because calcitonin does not cross the placenta, this adverse fetal effect may result from metabolic effects of calcitonin in the pregnant animal. Parenteral calcitonin salmon should be used during pregnancy only when the potential benefits justify the possible risks to the fetus. Calcitonin salmon nasal spray should not be used in pregnant women.

Calcitonin inhibits lactation in animals. It is not known whether calcitonin salmon is distributed into milk, although drug distributed into milk and ingested by the infant is likely to be inactivated in the GI tract and therefore unlikely to be absorbed by the nursing infant. Because studies to determine GI absorption of calcitonin in nursing infants have not been performed to date, use of calcitonin salmon in nursing women is not recommended.

No enhanced Geriatric Use information available for this drug.